UK Grants Innovation Passports to Three Investigational Therapies
The UK has awarded Innovation Passports to three investigational therapies targeting lung cancer, Huntington’s disease, and Alzheimer's. These designations are part of the Innovative Licensing and Access Pathway, aimed at accelerating access to promising new treatments. The Medicines and Healthcare products Regulatory Agency (MHRA) recognized these novel drugs to support their development and potential availability in the UK.
Medscape·



